Filing Details
- Accession Number:
- 0001209191-20-023971
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-08 19:21:47
- Reporting Period:
- 2020-04-06
- Accepted Time:
- 2020-04-08 19:21:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1772259 | Jean Jingrong Cui | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-06 | 1,100 | $41.46 | 780,991 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-06 | 2,998 | $42.61 | 777,993 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-06 | 11,212 | $43.72 | 766,781 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-06 | 2,890 | $44.22 | 763,891 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-06 | 300 | $45.13 | 763,591 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-07 | 4,500 | $43.69 | 759,091 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-07 | 8,100 | $44.96 | 750,991 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-07 | 5,900 | $45.63 | 745,091 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-08 | 6,294 | $45.89 | 738,797 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-08 | 12,106 | $46.43 | 726,691 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-04-08 | 100 | $47.23 | 726,591 | No | 4 | S | Indirect | By spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,001,298 | Direct | |
Common Stock | 300,000 | Indirect | By The Jean Cui 2020 GRAT |
Footnotes
- Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
- The weighted average sale price for the transaction reported was $41.46, and the range of prices were between $40.96 and $41.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $42.61, and the range of prices were between $42.08 and $43.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $43.72, and the range of prices were between $43.085 and $44.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $44.22, and the range of prices were between $44.09 and $44.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $45.13, and the range of prices were between $45.09 and $45.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $43.69, and the range of prices were between $43.21 and $44.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $44.96, and the range of prices were between $44.32 and $45.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $45.63, and the range of prices were between $45.32 and $46.235. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $45.885, and the range of prices were between $45.13 and $46.125. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $46.43, and the range of prices were between $46.13 and $47.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.